Literature DB >> 19128357

Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell.

J Spencer, M Peakman.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19128357      PMCID： PMC2675241          DOI： 10.1111/j.1365-2249.2008.03864.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  12 in total

1.  Development of type 1 diabetes despite severe hereditary B-cell deficiency.

Authors:  S Martin; D Wolf-Eichbaum; G Duinkerken; W A Scherbaum; H Kolb; J G Noordzij; B O Roep
Journal:  N Engl J Med       Date:  2001-10-04       Impact factor: 91.245

Review 2.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.

Authors:  Miriam Cnop; Nils Welsh; Jean-Christophe Jonas; Anne Jörns; Sigurd Lenzen; Decio L Eizirik
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

3.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

4.  Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus.

Authors:  A Hänninen; S Jalkanen; M Salmi; S Toikkanen; G Nikolakaros; O Simell
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

5.  Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice.

Authors:  Chang-yun Hu; Daniel Rodriguez-Pinto; Wei Du; Anupama Ahuja; Octavian Henegariu; F Susan Wong; Mark J Shlomchik; Li Wen
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Authors:  G F Bottazzo; B M Dean; J M McNally; E H MacKay; P G Swift; D R Gamble
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

7.  Analysis of islet inflammation in human type 1 diabetes.

Authors:  A Willcox; S J Richardson; A J Bone; A K Foulis; N G Morgan
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

8.  Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile.

Authors:  N Somoza; F Vargas; C Roura-Mir; M Vives-Pi; M T Fernández-Figueras; A Ariza; R Gomis; R Bragado; M Martí; D Jaraquemada; R Pujol-Borrell
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

Review 9.  Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.

Authors:  T Staeva-Vieira; M Peakman; M von Herrath
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 10.  Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.

Authors:  T P Di Lorenzo; M Peakman; B O Roep
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330
View more
  13 in total

Review 1.  Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes.

Authors:  Bart O Roep; Mark Peakman
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

Review 2.  Type 1 diabetes: A predictable disease.

Authors:  Kimber M Simmons; Aaron W Michels
Journal:  World J Diabetes       Date:  2015-04-15

Review 3.  Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.

Authors:  Kimber Simmons; Aaron W Michels
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

4.  Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group.

Authors:  J B Matthews; T P Staeva; P L Bernstein; M Peakman; M von Herrath
Journal:  Clin Exp Immunol       Date:  2010-05       Impact factor: 4.330

5.  Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients.

Authors:  Shiva Reddy; Nina Zeng; Hussam Al-Diery; Doran Jung; Clifton Yeu; Maximilian O Joret; Mervyn J Merrilees; Fiona Wu
Journal:  Diabetologia       Date:  2015-02-17       Impact factor: 10.122

6.  DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.

Authors:  Jeffrey D Price; Chie Hotta-Iwamura; Yongge Zhao; Nicole M Beauchamp; Kristin V Tarbell
Journal:  Diabetes       Date:  2015-06-12       Impact factor: 9.461

7.  Islet inflammation and CXCL10 in recent-onset type 1 diabetes.

Authors:  B O Roep; F S Kleijwegt; A G S van Halteren; V Bonato; U Boggi; F Vendrame; P Marchetti; F Dotta
Journal:  Clin Exp Immunol       Date:  2010-01-05       Impact factor: 4.330

8.  Dimorphic histopathology of long-standing childhood-onset diabetes.

Authors:  R Gianani; M Campbell-Thompson; S A Sarkar; C Wasserfall; A Pugliese; J M Solis; S C Kent; B J Hering; E West; A Steck; S Bonner-Weir; M A Atkinson; K Coppieters; M von Herrath; G S Eisenbarth
Journal:  Diabetologia       Date:  2010-01-09       Impact factor: 10.122

9.  Histopathology of type 1 diabetes: old paradigms and new insights.

Authors:  Ken T Coppieters; Matthias G von Herrath
Journal:  Rev Diabet Stud       Date:  2009-08-10

Review 10.  The streetlight effect in type 1 diabetes.

Authors:  Manuela Battaglia; Mark A Atkinson
Journal:  Diabetes       Date:  2015-04       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.